| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Pregnancy Complications, Infectious | 40 | 2021 | 11559 | 2.55 | Why? |
| Contraception | 5 | 2020 | 291 | 1.89 | Why? |
| Zika Virus Infection | 15 | 2019 | 1920 | 1.78 | Why? |
| Family Planning Services | 5 | 2020 | 236 | 1.43 | Why? |
| Pregnancy | 61 | 2021 | 23879 | 1.42 | Why? |
| Infectious Disease Transmission, Vertical | 14 | 2021 | 5164 | 1.35 | Why? |
| Contraceptives, Oral, Hormonal | 2 | 2017 | 42 | 1.33 | Why? |
| Pregnant Women | 6 | 2021 | 2535 | 1.08 | Why? |
| Obstetrics | 3 | 2020 | 859 | 0.93 | Why? |
| Reproductive Techniques, Assisted | 9 | 2018 | 400 | 0.92 | Why? |
| Fertilization | 2 | 2018 | 49 | 0.88 | Why? |
| Contraceptive Agents, Female | 2 | 2017 | 41 | 0.85 | Why? |
| Contraceptives, Oral, Combined | 2 | 2017 | 20 | 0.84 | Why? |
| Reproductive Medicine | 1 | 2021 | 109 | 0.75 | Why? |
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2019 | 91 | 0.74 | Why? |
| HIV Seronegativity | 2 | 2017 | 112 | 0.72 | Why? |
| Long-Acting Reversible Contraception | 1 | 2017 | 9 | 0.71 | Why? |
| Hemorrhagic Fever, Ebola | 3 | 2018 | 1475 | 0.71 | Why? |
| Sterilization, Reproductive | 1 | 2017 | 13 | 0.71 | Why? |
| HIV Infections | 15 | 2019 | 11620 | 0.70 | Why? |
| Migraine without Aura | 1 | 2016 | 14 | 0.68 | Why? |
| Preconception Care | 1 | 2017 | 49 | 0.68 | Why? |
| Pregnancy Outcome | 13 | 2021 | 3803 | 0.67 | Why? |
| Zika Virus | 9 | 2019 | 1924 | 0.66 | Why? |
| Migraine with Aura | 1 | 2016 | 33 | 0.65 | Why? |
| Postpartum Period | 2 | 2021 | 936 | 0.65 | Why? |
| Maternal Health | 2 | 2018 | 331 | 0.63 | Why? |
| HIV Seropositivity | 2 | 2017 | 320 | 0.61 | Why? |
| West Nile Fever | 1 | 2017 | 166 | 0.56 | Why? |
| Local Government | 1 | 2017 | 301 | 0.55 | Why? |
| State Government | 2 | 2019 | 416 | 0.53 | Why? |
| Fetus | 4 | 2019 | 484 | 0.53 | Why? |
| Gynecology | 2 | 2018 | 741 | 0.52 | Why? |
| Health Knowledge, Attitudes, Practice | 4 | 2021 | 8811 | 0.51 | Why? |
| United States | 33 | 2021 | 46150 | 0.48 | Why? |
| Infant, Newborn | 23 | 2021 | 23105 | 0.47 | Why? |
| Anti-Retroviral Agents | 2 | 2017 | 1099 | 0.46 | Why? |
| Public Health Practice | 2 | 2017 | 945 | 0.45 | Why? |
| Public Health | 4 | 2021 | 16359 | 0.45 | Why? |
| Prenatal Care | 3 | 2019 | 1314 | 0.45 | Why? |
| Population Health | 1 | 2018 | 504 | 0.44 | Why? |
| Maternal Health Services | 1 | 2020 | 808 | 0.44 | Why? |
| Practice Guidelines as Topic | 9 | 2021 | 15421 | 0.41 | Why? |
| Breast Feeding | 5 | 2021 | 1585 | 0.41 | Why? |
| Female | 70 | 2021 | 380317 | 0.39 | Why? |
| Civil Defense | 1 | 2021 | 1687 | 0.39 | Why? |
| Microcephaly | 3 | 2018 | 181 | 0.34 | Why? |
| Coronavirus | 4 | 2020 | 18339 | 0.33 | Why? |
| Embryo Transfer | 2 | 2017 | 91 | 0.32 | Why? |
| Georgia | 2 | 2020 | 955 | 0.31 | Why? |
| Influenza Vaccines | 2 | 2019 | 2941 | 0.31 | Why? |
| Influenza A Virus, H1N1 Subtype | 2 | 2019 | 2984 | 0.31 | Why? |
| Decision Making | 1 | 2020 | 3132 | 0.30 | Why? |
| Premature Birth | 6 | 2021 | 2151 | 0.30 | Why? |
| Infertility | 3 | 2019 | 247 | 0.29 | Why? |
| Pregnancy Rate | 4 | 2017 | 134 | 0.28 | Why? |
| Sex Education | 2 | 2019 | 18 | 0.28 | Why? |
| Communicable Diseases, Emerging | 3 | 2021 | 2523 | 0.27 | Why? |
| Humans | 78 | 2021 | 930598 | 0.27 | Why? |
| Women's Health | 1 | 2008 | 444 | 0.25 | Why? |
| Socioeconomic Factors | 2 | 2020 | 8495 | 0.25 | Why? |
| Infant, Low Birth Weight | 5 | 2017 | 243 | 0.25 | Why? |
| Pneumonia, Viral | 10 | 2021 | 243684 | 0.24 | Why? |
| Pandemics | 15 | 2021 | 389249 | 0.23 | Why? |
| Disease Outbreaks | 9 | 2020 | 27595 | 0.23 | Why? |
| Pregnancy, Unplanned | 2 | 2019 | 36 | 0.23 | Why? |
| Botulism | 2 | 2017 | 18 | 0.22 | Why? |
| Live Birth | 3 | 2017 | 200 | 0.22 | Why? |
| Congenital Abnormalities | 3 | 2017 | 170 | 0.22 | Why? |
| Anti-HIV Agents | 4 | 2017 | 2209 | 0.22 | Why? |
| Physicians | 1 | 2020 | 4214 | 0.21 | Why? |
| Coronavirus Infections | 10 | 2020 | 253789 | 0.21 | Why? |
| Pregnancy, Multiple | 2 | 2017 | 46 | 0.21 | Why? |
| Vaccination | 4 | 2021 | 19050 | 0.21 | Why? |
| Adolescent Behavior | 1 | 2006 | 400 | 0.20 | Why? |
| Fertility Agents | 1 | 2019 | 4 | 0.20 | Why? |
| Maternal-Fetal Exchange | 1 | 2021 | 209 | 0.20 | Why? |
| Population Surveillance | 7 | 2017 | 4967 | 0.20 | Why? |
| Fertility | 3 | 2018 | 367 | 0.19 | Why? |
| Tetanus | 1 | 2019 | 61 | 0.19 | Why? |
| Pregnancy in Adolescence | 1 | 2018 | 22 | 0.19 | Why? |
| Diphtheria | 1 | 2019 | 74 | 0.19 | Why? |
| Influenza, Human | 3 | 2019 | 10779 | 0.19 | Why? |
| Infant | 11 | 2021 | 30274 | 0.19 | Why? |
| HIV-1 | 5 | 2012 | 3365 | 0.18 | Why? |
| Attitude of Health Personnel | 1 | 2017 | 4741 | 0.18 | Why? |
| GB virus C | 1 | 2017 | 8 | 0.18 | Why? |
| Placenta | 2 | 2020 | 1531 | 0.18 | Why? |
| Puerperal Infection | 1 | 2017 | 26 | 0.18 | Why? |
| Lactation | 1 | 2021 | 361 | 0.18 | Why? |
| Single Embryo Transfer | 1 | 2017 | 2 | 0.18 | Why? |
| Delivery, Obstetric | 2 | 2018 | 1292 | 0.18 | Why? |
| Flaviviridae Infections | 1 | 2017 | 27 | 0.18 | Why? |
| Medroxyprogesterone Acetate | 1 | 2017 | 10 | 0.17 | Why? |
| Biological Warfare | 1 | 2017 | 19 | 0.17 | Why? |
| Intrauterine Devices, Medicated | 1 | 2017 | 12 | 0.17 | Why? |
| Achievement | 1 | 2017 | 28 | 0.17 | Why? |
| Embryo Disposition | 1 | 2016 | 2 | 0.17 | Why? |
| Antibody Formation | 2 | 2021 | 4038 | 0.17 | Why? |
| Ovarian Reserve | 1 | 2017 | 45 | 0.17 | Why? |
| Mastitis | 1 | 2017 | 27 | 0.17 | Why? |
| Epidemics | 1 | 2017 | 6407 | 0.17 | Why? |
| Medical Tourism | 1 | 2017 | 53 | 0.16 | Why? |
| Whooping Cough | 1 | 2019 | 201 | 0.16 | Why? |
| Bioterrorism | 1 | 2017 | 105 | 0.16 | Why? |
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2017 | 170 | 0.16 | Why? |
| Abortion, Legal | 1 | 2017 | 67 | 0.16 | Why? |
| Sexual Behavior | 1 | 2006 | 1322 | 0.16 | Why? |
| Medically Underserved Area | 1 | 2019 | 273 | 0.16 | Why? |
| Financing, Personal | 1 | 2017 | 113 | 0.16 | Why? |
| Women | 1 | 2019 | 159 | 0.16 | Why? |
| Infant, Newborn, Diseases | 2 | 2018 | 394 | 0.15 | Why? |
| Prenatal Exposure Delayed Effects | 2 | 2017 | 319 | 0.15 | Why? |
| Obesity | 1 | 2017 | 7388 | 0.15 | Why? |
| Adult | 32 | 2021 | 244371 | 0.15 | Why? |
| Malawi | 4 | 2017 | 287 | 0.15 | Why? |
| West Nile virus | 1 | 2017 | 206 | 0.15 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.15 | Why? |
| Young Adult | 17 | 2021 | 93724 | 0.15 | Why? |
| Culicidae | 1 | 2017 | 239 | 0.14 | Why? |
| Pregnancy, Twin | 1 | 2016 | 133 | 0.14 | Why? |
| Infertility, Female | 1 | 2017 | 150 | 0.14 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2018 | 9706 | 0.14 | Why? |
| Insurance, Health | 2 | 2017 | 634 | 0.14 | Why? |
| Health Personnel | 3 | 2020 | 29646 | 0.14 | Why? |
| Government Programs | 1 | 2019 | 512 | 0.14 | Why? |
| Logistic Models | 4 | 2017 | 9089 | 0.14 | Why? |
| Chemoprevention | 2 | 2017 | 585 | 0.14 | Why? |
| Adolescent | 16 | 2019 | 86841 | 0.14 | Why? |
| Spermatozoa | 1 | 2017 | 244 | 0.14 | Why? |
| Abortion, Spontaneous | 2 | 2020 | 776 | 0.14 | Why? |
| Zoonoses | 1 | 2008 | 3034 | 0.14 | Why? |
| Neuroimaging | 2 | 2019 | 1106 | 0.14 | Why? |
| Mosquito Vectors | 1 | 2017 | 351 | 0.13 | Why? |
| Infection Control | 2 | 2020 | 23131 | 0.13 | Why? |
| Health Services Accessibility | 1 | 2017 | 10697 | 0.13 | Why? |
| Travel-Related Illness | 1 | 2021 | 1357 | 0.13 | Why? |
| Societies, Medical | 2 | 2021 | 6907 | 0.13 | Why? |
| Stroke | 1 | 2016 | 8839 | 0.13 | Why? |
| Health Expenditures | 2 | 2019 | 904 | 0.13 | Why? |
| Visitors to Patients | 1 | 2020 | 671 | 0.12 | Why? |
| Climate Change | 1 | 2021 | 901 | 0.12 | Why? |
| Risk Assessment | 5 | 2020 | 25439 | 0.12 | Why? |
| Clinical Trials as Topic | 3 | 2021 | 7330 | 0.12 | Why? |
| Hepatitis C Antibodies | 1 | 2012 | 120 | 0.11 | Why? |
| Semen | 1 | 2017 | 550 | 0.11 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.11 | Why? |
| Antiretroviral Therapy, Highly Active | 1 | 2017 | 952 | 0.11 | Why? |
| Autistic Disorder | 1 | 2015 | 253 | 0.11 | Why? |
| Chemokines | 1 | 2017 | 1095 | 0.11 | Why? |
| HIV | 1 | 2018 | 1116 | 0.11 | Why? |
| Drug Interactions | 1 | 2017 | 1653 | 0.10 | Why? |
| Urban Population | 1 | 2020 | 2000 | 0.10 | Why? |
| Betacoronavirus | 9 | 2020 | 204454 | 0.10 | Why? |
| Databases, Factual | 4 | 2017 | 6248 | 0.10 | Why? |
| Odds Ratio | 3 | 2017 | 5861 | 0.10 | Why? |
| Milk, Human | 1 | 2018 | 956 | 0.10 | Why? |
| Stillbirth | 1 | 2014 | 544 | 0.10 | Why? |
| Infant, Premature, Diseases | 1 | 2008 | 74 | 0.09 | Why? |
| Puerto Rico | 2 | 2019 | 177 | 0.09 | Why? |
| Viral Load | 2 | 2020 | 15850 | 0.09 | Why? |
| Cohort Studies | 3 | 2021 | 36005 | 0.09 | Why? |
| Case-Control Studies | 2 | 2017 | 17671 | 0.09 | Why? |
| Health Priorities | 1 | 2017 | 959 | 0.09 | Why? |
| Pre-Exposure Prophylaxis | 1 | 2017 | 1138 | 0.09 | Why? |
| Child, Abandoned | 1 | 2007 | 4 | 0.09 | Why? |
| Infant, Premature | 3 | 2017 | 883 | 0.09 | Why? |
| Multivariate Analysis | 2 | 2017 | 5440 | 0.08 | Why? |
| Guidelines as Topic | 1 | 2020 | 2844 | 0.08 | Why? |
| Health Care Surveys | 1 | 2017 | 2942 | 0.08 | Why? |
| Politics | 1 | 2020 | 1824 | 0.08 | Why? |
| AIDS Serodiagnosis | 1 | 2007 | 64 | 0.08 | Why? |
| Health Services Needs and Demand | 1 | 2021 | 3419 | 0.08 | Why? |
| Fetal Diseases | 2 | 2018 | 182 | 0.08 | Why? |
| Birth Rate | 2 | 2017 | 137 | 0.08 | Why? |
| Social Determinants of Health | 1 | 2018 | 1757 | 0.08 | Why? |
| Cough | 1 | 2020 | 4891 | 0.08 | Why? |
| Safe Sex | 1 | 2006 | 135 | 0.07 | Why? |
| Survivors | 1 | 2018 | 2619 | 0.07 | Why? |
| Periodicals as Topic | 1 | 2018 | 1492 | 0.07 | Why? |
| Prevalence | 5 | 2020 | 25773 | 0.07 | Why? |
| Antimalarials | 1 | 2017 | 2505 | 0.07 | Why? |
| Brain | 2 | 2019 | 5133 | 0.07 | Why? |
| Insurance Coverage | 2 | 2019 | 348 | 0.07 | Why? |
| Behavior Therapy | 1 | 2006 | 235 | 0.06 | Why? |
| Fever | 1 | 2020 | 7795 | 0.06 | Why? |
| Trichomonas Infections | 1 | 2002 | 24 | 0.06 | Why? |
| Colombia | 2 | 2018 | 1241 | 0.06 | Why? |
| Disease Transmission, Infectious | 1 | 2006 | 9044 | 0.06 | Why? |
| Hepacivirus | 1 | 2012 | 1509 | 0.06 | Why? |
| Travel | 1 | 2021 | 7220 | 0.06 | Why? |
| Forecasting | 1 | 2017 | 4492 | 0.06 | Why? |
| Carrier Proteins | 1 | 1985 | 513 | 0.06 | Why? |
| Retrospective Studies | 9 | 2019 | 105322 | 0.06 | Why? |
| Male | 10 | 2018 | 367725 | 0.06 | Why? |
| Communication | 1 | 2019 | 5206 | 0.05 | Why? |
| Hepatitis C | 1 | 2012 | 1514 | 0.05 | Why? |
| Risk Factors | 9 | 2021 | 71621 | 0.05 | Why? |
| Health Status Disparities | 1 | 2018 | 4072 | 0.05 | Why? |
| United States Virgin Islands | 1 | 2019 | 8 | 0.05 | Why? |
| Healthcare Disparities | 1 | 2017 | 3893 | 0.05 | Why? |
| RNA, Viral | 3 | 2017 | 32276 | 0.05 | Why? |
| Gestational Age | 2 | 2017 | 1488 | 0.05 | Why? |
| Botulinum Antitoxin | 1 | 2017 | 6 | 0.05 | Why? |
| Patient Acceptance of Health Care | 1 | 2017 | 5002 | 0.05 | Why? |
| Sexual Abstinence | 1 | 2017 | 5 | 0.04 | Why? |
| Seasons | 1 | 2011 | 4071 | 0.04 | Why? |
| Glanders | 1 | 2017 | 1 | 0.04 | Why? |
| Insect Repellents | 1 | 2017 | 23 | 0.04 | Why? |
| Treatment Outcome | 4 | 2017 | 51732 | 0.04 | Why? |
| Health Policy | 1 | 2018 | 6242 | 0.04 | Why? |
| Typhus, Epidemic Louse-Borne | 1 | 2017 | 17 | 0.04 | Why? |
| Prospective Studies | 5 | 2021 | 43301 | 0.04 | Why? |
| Hypertension | 1 | 2019 | 8895 | 0.04 | Why? |
| Neural Tube Defects | 1 | 2017 | 35 | 0.04 | Why? |
| Biological Warfare Agents | 1 | 2017 | 24 | 0.04 | Why? |
| Eye Abnormalities | 1 | 2017 | 29 | 0.04 | Why? |
| Apgar Score | 1 | 2017 | 77 | 0.04 | Why? |
| Internship and Residency | 1 | 2018 | 4987 | 0.04 | Why? |
| Ebola Vaccines | 1 | 2018 | 126 | 0.04 | Why? |
| Tularemia | 1 | 2017 | 25 | 0.04 | Why? |
| Anthrax | 1 | 2017 | 35 | 0.04 | Why? |
| Escherichia coli | 1 | 1985 | 1547 | 0.04 | Why? |
| Incidence | 3 | 2016 | 25622 | 0.04 | Why? |
| Child | 4 | 2017 | 70012 | 0.04 | Why? |
| Democratic Republic of the Congo | 1 | 2018 | 500 | 0.04 | Why? |
| Melioidosis | 1 | 2017 | 50 | 0.04 | Why? |
| Interleukin-12 | 1 | 2017 | 156 | 0.04 | Why? |
| Perinatal Mortality | 1 | 2017 | 120 | 0.04 | Why? |
| Maternal Age | 1 | 2017 | 244 | 0.04 | Why? |
| District of Columbia | 1 | 2017 | 343 | 0.04 | Why? |
| Transforming Growth Factor beta1 | 1 | 2017 | 204 | 0.04 | Why? |
| Child, Preschool | 2 | 2017 | 36283 | 0.04 | Why? |
| Interleukin-4 | 1 | 2017 | 367 | 0.04 | Why? |
| Maternal-Child Health Services | 1 | 2017 | 124 | 0.04 | Why? |
| Condoms | 1 | 2017 | 235 | 0.04 | Why? |
| Smallpox | 1 | 2017 | 96 | 0.04 | Why? |
| Repressor Proteins | 1 | 1997 | 232 | 0.04 | Why? |
| Authorship | 1 | 2018 | 240 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.04 | Why? |
| Interleukin-2 | 1 | 2017 | 443 | 0.04 | Why? |
| Goals | 1 | 2018 | 335 | 0.04 | Why? |
| Birth Weight | 1 | 2017 | 250 | 0.04 | Why? |
| Middle Aged | 7 | 2019 | 270681 | 0.04 | Why? |
| Mosquito Control | 1 | 2017 | 237 | 0.04 | Why? |
| Cytokines | 1 | 2017 | 15010 | 0.04 | Why? |
| Focus Groups | 1 | 2019 | 811 | 0.04 | Why? |
| Global Health | 1 | 2018 | 13911 | 0.04 | Why? |
| Infant Mortality | 1 | 2017 | 268 | 0.03 | Why? |
| Membrane Proteins | 1 | 1985 | 1733 | 0.03 | Why? |
| Animals | 3 | 2017 | 78931 | 0.03 | Why? |
| Cellular Senescence | 1 | 1997 | 326 | 0.03 | Why? |
| Health Plan Implementation | 1 | 2019 | 571 | 0.03 | Why? |
| Plague | 1 | 2017 | 155 | 0.03 | Why? |
| Chi-Square Distribution | 1 | 2017 | 961 | 0.03 | Why? |
| Africa South of the Sahara | 1 | 2018 | 1335 | 0.03 | Why? |
| Protective Clothing | 1 | 2017 | 468 | 0.03 | Why? |
| Fertilization in Vitro | 1 | 2017 | 330 | 0.03 | Why? |
| Postnatal Care | 1 | 2017 | 346 | 0.03 | Why? |
| Ultrasonography, Prenatal | 1 | 2017 | 471 | 0.03 | Why? |
| Maternal Mortality | 1 | 2017 | 461 | 0.03 | Why? |
| Respiratory Tract Infections | 1 | 2014 | 6817 | 0.03 | Why? |
| Latin America | 1 | 2018 | 1721 | 0.03 | Why? |
| Birth Certificates | 1 | 2012 | 34 | 0.03 | Why? |
| History, 21st Century | 1 | 2019 | 1849 | 0.03 | Why? |
| Hemoglobins | 1 | 2017 | 958 | 0.03 | Why? |
| Central Nervous System Diseases | 1 | 2017 | 410 | 0.03 | Why? |
| Asia | 1 | 2018 | 2399 | 0.03 | Why? |
| Alanine Transaminase | 1 | 2017 | 1329 | 0.03 | Why? |
| Jordan | 1 | 2014 | 701 | 0.03 | Why? |
| Intensive Care Units, Neonatal | 1 | 2017 | 749 | 0.03 | Why? |
| Bibliometrics | 1 | 2018 | 731 | 0.03 | Why? |
| Morbidity | 1 | 2017 | 1426 | 0.03 | Why? |
| Genotype | 2 | 2017 | 4697 | 0.03 | Why? |
| Mitochondria | 1 | 1997 | 857 | 0.03 | Why? |
| North Carolina | 1 | 1992 | 571 | 0.03 | Why? |
| Proteins | 1 | 1997 | 921 | 0.02 | Why? |
| Registries | 2 | 2021 | 12327 | 0.02 | Why? |
| Propensity Score | 1 | 2017 | 2690 | 0.02 | Why? |
| Public Health Administration | 1 | 2017 | 846 | 0.02 | Why? |
| Income | 1 | 2017 | 1564 | 0.02 | Why? |
| Malaria | 1 | 2017 | 1097 | 0.02 | Why? |
| Pregnancy, Unwanted | 1 | 2007 | 29 | 0.02 | Why? |
| Leukocyte Count | 1 | 2017 | 3178 | 0.02 | Why? |
| Massachusetts | 1 | 2012 | 1279 | 0.02 | Why? |
| Mothers | 1 | 2018 | 1624 | 0.02 | Why? |
| Time Factors | 3 | 2017 | 31397 | 0.02 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.02 | Why? |
| beta-Galactosidase | 1 | 1985 | 40 | 0.02 | Why? |
| World Health Organization | 1 | 2018 | 4213 | 0.02 | Why? |
| International Cooperation | 1 | 2018 | 3436 | 0.02 | Why? |
| Mass Screening | 2 | 2017 | 8005 | 0.02 | Why? |
| Dietary Supplements | 1 | 2017 | 2251 | 0.02 | Why? |
| Biological Transport | 1 | 1985 | 290 | 0.02 | Why? |
| Bacterial Infections | 1 | 2017 | 2229 | 0.02 | Why? |
| Russia | 1 | 2007 | 989 | 0.02 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.01 | Why? |
| Pregnancy Trimester, Third | 1 | 2003 | 445 | 0.01 | Why? |
| Pregnancy Trimester, First | 1 | 2003 | 366 | 0.01 | Why? |
| Immunologic Factors | 1 | 2017 | 4206 | 0.01 | Why? |
| Species Specificity | 1 | 1985 | 1356 | 0.01 | Why? |
| Pregnancy Complications | 1 | 2012 | 1388 | 0.01 | Why? |
| Poverty | 1 | 1992 | 2302 | 0.01 | Why? |
| Models, Statistical | 1 | 2018 | 5312 | 0.01 | Why? |
| Patient Admission | 1 | 2017 | 5250 | 0.01 | Why? |
| Cell Membrane | 1 | 1985 | 743 | 0.01 | Why? |
| Amino Acid Sequence | 2 | 1997 | 6049 | 0.01 | Why? |
| Hospitalization | 1 | 2011 | 54280 | 0.01 | Why? |
| Program Evaluation | 1 | 2007 | 1929 | 0.01 | Why? |
| Structure-Activity Relationship | 1 | 1985 | 2219 | 0.01 | Why? |
| Disease Progression | 1 | 2017 | 13580 | 0.01 | Why? |
| Caenorhabditis elegans Proteins | 1 | 1997 | 28 | 0.01 | Why? |
| Saccharomyces cerevisiae Proteins | 1 | 1997 | 66 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 11367 | 0.01 | Why? |
| HIV Antibodies | 1 | 2003 | 776 | 0.01 | Why? |
| African Americans | 1 | 1992 | 3363 | 0.01 | Why? |
| Decision Support Techniques | 1 | 2003 | 903 | 0.01 | Why? |
| Sequence Homology, Amino Acid | 1 | 1997 | 945 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.01 | Why? |
| Cost-Benefit Analysis | 1 | 2003 | 2259 | 0.01 | Why? |
| Recurrence | 1 | 2002 | 3675 | 0.01 | Why? |
| Molecular Sequence Data | 1 | 1997 | 3198 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2018 | 53120 | 0.01 | Why? |
| Protein Binding | 1 | 1985 | 11430 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2012 | 21571 | 0.01 | Why? |
| Comorbidity | 1 | 2011 | 34796 | 0.00 | Why? |
| Antiviral Agents | 1 | 2011 | 41703 | 0.00 | Why? |
| Mice | 1 | 1997 | 21357 | 0.00 | Why? |